Idexx Laboratories Company Profile (NASDAQ:IDXX)

About Idexx Laboratories

Idexx Laboratories logoIDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company's segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IDXX
  • CUSIP: 45168D10
Key Metrics:
  • Previous Close: $109.76
  • 50 Day Moving Average: $100.99
  • 200 Day Moving Average: $86.74
  • Trailing P/E Ratio: 49.76
  • Foreward P/E Ratio: 41.11
  • P/E Growth: 3.42
  • Market Cap: $9.83B
  • Outstanding Shares: 89,540,000
  • Beta: 0.6
Additional Links:
Companies Related to Idexx Laboratories:

Analyst Ratings

Consensus Ratings for Idexx Laboratories (NASDAQ:IDXX) (?)
Ratings Breakdown: 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $101.25 (7.75% downside)

Analysts' Ratings History for Idexx Laboratories (NASDAQ:IDXX)
DateFirmActionRatingPrice TargetDetails
8/22/2016Canaccord GenuityReiterated RatingBuy$120.00View Rating Details
8/16/2016Stifel NicolausBoost Price TargetBuy$120.00 -> $125.00View Rating Details
8/3/2016Northcoast ResearchUpgradeSell -> NeutralView Rating Details
4/13/2016Credit Suisse Group AGBoost Price TargetOutperform$80.00 -> $85.00View Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
2/1/2016Piper Jaffray Cos.Reiterated RatingNeutral$73.00 -> $75.00View Rating Details
1/31/2016William BlairReiterated RatingOutperformView Rating Details
8/28/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Feltl & Co.UpgradeSell -> Hold$61.50 -> $69.50View Rating Details
5/28/2015Bank of America Corp.Reiterated RatingBuy$168.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for Idexx Laboratories (NASDAQ:IDXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$0.62$0.74$444.83 million$467.00 millionViewListenView Earnings Details
4/29/2016Q116$0.47$0.51$403.48 million$417.55 millionViewListenView Earnings Details
1/29/2016Q415$0.44$0.48$397.39 million$400.00 millionViewListenView Earnings Details
10/28/2015Q315$0.53$0.54$409.33 million$406.00 millionViewListenView Earnings Details
7/30/2015Q215$0.57$0.60$412.57 million$413.30 millionViewListenView Earnings Details
4/28/2015Q115$0.99$0.98$394.38 million$382.00 millionViewN/AView Earnings Details
1/30/2015Q414$0.80$0.54$373.20 million$352.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.90$1.05$371.80 million$384.00 millionViewListenView Earnings Details
7/25/2014Q214$1.05$1.10$385.20 million$390.00 millionViewN/AView Earnings Details
4/25/2014Q114$0.87$0.89$361.58 million$360.20 millionViewListenView Earnings Details
2/4/2014Q413$0.81$0.82$347.08 million$354.10 millionViewN/AView Earnings Details
10/22/2013Q313$0.83$0.86$339.70 million$338.30 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.97$0.99$356.80 million$352.60 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.83$0.81$341.06 million$332.10 millionViewN/AView Earnings Details
1/29/2013Q4 2012$0.71$0.78$325.10 million$319.50 millionViewN/AView Earnings Details
10/19/2012$0.73$0.76ViewN/AView Earnings Details
7/20/2012$0.90$0.91ViewN/AView Earnings Details
4/20/2012$0.71$0.72ViewN/AView Earnings Details
1/27/2012$0.63$0.67ViewN/AView Earnings Details
10/21/2011$0.65$0.66ViewN/AView Earnings Details
7/22/2011$0.72$0.83ViewN/AView Earnings Details
4/21/2011$0.59$0.62ViewN/AView Earnings Details
1/28/2011$0.55$0.62ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Idexx Laboratories (NASDAQ:IDXX)
Current Year EPS Consensus Estimate: $2.36 EPS
Next Year EPS Consensus Estimate: $2.67 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.46$0.47$0.47
Q2 20163$0.62$0.63$0.63
Q3 20163$0.58$0.62$0.60
Q4 20163$0.49$0.54$0.51
Q1 20171$0.58$0.58$0.58
Q2 20171$0.88$0.88$0.88
Q3 20171$0.69$0.69$0.69
Q4 20171$0.55$0.55$0.55
(Data provided by Zacks Investment Research)


Dividend History for Idexx Laboratories (NASDAQ:IDXX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Idexx Laboratories (NASDAQ:IDXX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Barry C JohnsonDirectorSell9,924$111.37$1,105,235.88View SEC Filing  
8/8/2016Michael J. Phd WilliamsInsiderSell49,560$108.94$5,399,066.40View SEC Filing  
8/5/2016William T EndDirectorSell5,000$108.50$542,500.00View SEC Filing  
8/4/2016Jonathan W. AyersChairmanSell60,000$107.69$6,461,400.00View SEC Filing  
5/5/2016William T EndDirectorSell4,924$85.87$422,823.88View SEC Filing  
2/24/2016Michael J Phd WilliamsEVPSell2,000$71.93$143,860.00View SEC Filing  
2/9/2016Thomas CraigDirectorSell2,054$69.52$142,794.08View SEC Filing  
2/8/2016Brian P. MckeonCFOSell9,054$69.65$630,611.10View SEC Filing  
11/30/2015Thomas CraigDirectorSell7,000$70.28$491,960.00View SEC Filing  
11/12/2015Rebecca M. HendersonDirectorSell2,300$68.39$157,297.00View SEC Filing  
8/31/2015Thomas CraigDirectorSell800$71.77$57,416.00View SEC Filing  
8/18/2015Michael J. Phd WilliamsEVPSell6,586$78.34$515,947.24View SEC Filing  
8/18/2015Thomas CraigDirectorSell2,900$79.41$230,289.00View SEC Filing  
8/17/2015Jonathan W AyersCEOSell14,799$78.45$1,160,981.55View SEC Filing  
5/18/2015William T EndDirectorSell3,527$134.51$474,416.77View SEC Filing  
3/10/2015William T EndDirectorSell3,500$150.89$528,115.00View SEC Filing  
3/4/2015Johnny D PowersEVPSell6,168$158.49$977,566.32View SEC Filing  
2/17/2015Brian P MckeonCFOSell5,000$156.99$784,950.00View SEC Filing  
2/12/2015Jonathan W AyersCEOSell58,245$155.45$9,054,185.25View SEC Filing  
2/5/2015Rebecca M HendersonDirectorSell2,934$156.27$458,496.18View SEC Filing  
2/4/2015Thomas CraigDirectorSell2,200$157.02$345,444.00View SEC Filing  
1/14/2015Jonathan W AyersCEOSell28,512$157.68$4,495,772.16View SEC Filing  
12/3/2014Jonathan W AyersCEOSell29,000$148.49$4,306,210.00View SEC Filing  
11/13/2014Thomas CraigDirectorSell5,000$152.45$762,250.00View SEC Filing  
11/5/2014Jonathan W AyersCEOSell29,000$143.45$4,160,050.00View SEC Filing  
11/4/2014Johnny D PowersEVPSell1,292$142.70$184,368.40View SEC Filing  
8/13/2014M Anne SzostakDirectorBuy2,000$127.03$254,060.00View SEC Filing  
2/20/2014M Anne SzostakDirectorBuy2,000$126.71$253,420.00View SEC Filing  
2/19/2014Thomas CraigDirectorSell4,800$125.42$602,016.00View SEC Filing  
2/3/2014Jonathan AyersCEOSell81,294$112.46$9,142,323.24View SEC Filing  
11/26/2013Jonathan AyersCEOSell78,178$105.29$8,231,361.62View SEC Filing  
11/22/2013Sophie VandebroekDirectorBuy1,000$107.84$107,840.00View SEC Filing  
11/13/2013Jonathan AyersCEOSell78,178$106.36$8,315,012.08View SEC Filing  
11/4/2013M Anne SzostakDirectorBuy1,000$108.24$108,240.00View SEC Filing  
11/4/2013Michael Phd WilliamsEVPSell6,020$108.19$651,303.80View SEC Filing  
10/31/2013William T EndDirectorSell2,500$108.32$270,800.00View SEC Filing  
10/25/2013Jonathan W AyersCEOSell78,178$104.36$8,158,656.08View SEC Filing  
9/13/2013Johnny PowersEVPSell13,128$96.59$1,268,033.52View SEC Filing  
9/5/2013Michael J Phd WilliamsEVPSell5,162$95.58$493,383.96View SEC Filing  
5/9/2013Ali NaquiVPSell12,961$87.00$1,127,607.00View SEC Filing  
2/4/2013Merilee RainesCFOSell175,929$94.25$16,581,308.25View SEC Filing  
11/13/2012Jonathan W AyersCEOSell15,000$89.92$1,348,800.00View SEC Filing  
9/5/2012Johnny D PowersEVPSell4,000$97.12$388,480.00View SEC Filing  
8/8/2012Merilee RainesCFOSell7,726$88.84$686,377.84View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Idexx Laboratories (NASDAQ:IDXX)
DateHeadline logoAnalysts Estimate IDEXX Laboratories, Inc. (NASDAQ:IDXX) Will Achieve An EPS Growth Of 14% In Next 5 Years - (NASDAQ:IDXX) - August 22 at 5:38 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Reports Accounts Payable Of $50.085 - (NASDAQ:IDXX) - August 20 at 9:46 AM logoUptrend Call Working As Idexx Laboratories Stock Rises 54.4% (IDXX) (NASDAQ:IDXX) - August 19 at 8:32 AM logoIDEXX Investor Day (NASDAQ:IDXX) - August 17 at 5:47 PM logoBaron Funds Comments on IDEXX Laboratories (NASDAQ:IDXX) - August 17 at 5:47 PM
News IconTop Gainers of the Day: IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances (NASDAQ:IDXX) - August 17 at 8:39 AM logoIDEXX LABORATORIES INC /DE Financials (NASDAQ:IDXX) - August 9 at 5:45 PM logoIDEXX Laboratories to Host 2016 Investor Day (NASDAQ:IDXX) - August 8 at 5:46 PM logoCMCSA, IDXX, ZTS: Jim Cramer's Views (NASDAQ:IDXX) - August 8 at 10:16 AM
News IconHC Stocks Growth: Vertex Pharmaceuticals Incorporated (NASDAQ ... - share market updates (press release) (NASDAQ:IDXX) - August 6 at 8:26 AM logoETF’s with exposure to IDEXX Laboratories, Inc. : August 5, 2016 (NASDAQ:IDXX) - August 5 at 5:42 PM logoIdexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6.5 million of Stocks - (NASDAQ:IDXX) - August 5 at 8:31 AM logoIdexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6. ... (NASDAQ:IDXX) - August 5 at 8:31 AM logoHas IDEXX Labs Hit an Exhaustion Gap? (NASDAQ:IDXX) - August 4 at 5:52 PM logoIDEXX Laboratories Exceeds Expectations (NASDAQ:IDXX) - August 4 at 1:14 PM logoIDEXX Laboratories Inc. (IDXX) Soared To A New High On Q2 Results (NASDAQ:IDXX) - August 3 at 5:53 PM logoIDEXX Laboratories, Inc. :IDXX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:IDXX) - August 3 at 5:53 PM logoNoteworthy Analyst's Rating to Observe: Biogen Inc. (NASDAQ:BIIB) , IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Street Updates (NASDAQ:IDXX) - August 3 at 8:48 AM logoIDEXX Laboratories Inc (NASDAQ:IDXX) Released Q2 Net Income of $67.2 Million - Street Report (NASDAQ:IDXX) - August 3 at 8:48 AM logoEdited Transcript of IDXX earnings conference call or presentation 2-Aug-16 12:30pm GMT (NASDAQ:IDXX) - August 3 at 8:48 AM
News IconIdexx posts record high stock price following strong earnings report (NASDAQ:IDXX) - August 2 at 5:48 PM logoWhy IDEXX Laboratories, Inc. Reported Higher Today (NASDAQ:IDXX) - August 2 at 2:00 PM logoIDEXX Laboratories Announces Second Quarter Results (NASDAQ:IDXX) - August 2 at 10:23 AM logoIDEXX Laboratories Inc. (IDXX) Has Soared To A New High On Strong Q2 Results (NASDAQ:IDXX) - August 2 at 10:23 AM logoIdexx beats Street 2Q forecasts (NASDAQ:IDXX) - August 2 at 10:23 AM logoIDEXX Laboratories Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:IDXX) - August 2 at 10:23 AM logoWhy Earnings Season Could Be Great for IDEXX Laboratories (IDXX) (NASDAQ:IDXX) - August 1 at 10:22 AM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NASDAQ:IDXX) - July 28 at 8:33 AM
News IconIDEXX Releases Revolutionary Water Test to Aid in the Fight Against Legionnaires’ Disease (NASDAQ:IDXX) - July 27 at 5:51 PM logoWill IDEXX Laboratories, Inc. (NASDAQ:IDXX) Surprise Analysts? - Investor Newswire (NASDAQ:IDXX) - July 27 at 8:23 AM logoIDEXX Releases Revolutionary Water Test to Aid in the Fight Against Legionnaires' Disease (NASDAQ:IDXX) - July 27 at 8:04 AM logoBaron Funds Comments on IDEXX Laboratories Inc. (NASDAQ:IDXX) - July 25 at 12:57 PM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:IDXX) - July 23 at 9:35 AM
News IconFriday Session Wrap-up for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Engelwood Daily (NASDAQ:IDXX) - July 23 at 9:35 AM
News IconEquity Roundup: Stock Performance Focus on IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Press Telegraph (NASDAQ:IDXX) - July 22 at 8:31 AM logoCanaccord Believes IDEXX Labs Can Meet Guidance (NASDAQ:IDXX) - July 21 at 11:36 AM
News IconLong Term Value Play: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - TGP (NASDAQ:IDXX) - July 20 at 8:33 AM
News IconStock Positive on the Year: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - TGP (NASDAQ:IDXX) - July 20 at 8:33 AM logoPrice Target of $77.8 Set For IDEXX Laboratories, Inc. (NASDAQ:IDXX) - (NASDAQ:IDXX) - July 20 at 8:33 AM
News IconShares Positive Over the Past Month: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - TGP (NASDAQ:IDXX) - July 20 at 8:33 AM
News IconStock Strength in Focus for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Press Telegraph (NASDAQ:IDXX) - July 20 at 8:33 AM
News IconShares Experiencing a Downtrend: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - TGP (NASDAQ:IDXX) - July 16 at 5:21 PM
News IconAnalyst Target and Average Rating Watch: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Press Telegraph (NASDAQ:IDXX) - July 15 at 4:37 PM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:IDXX) - July 15 at 4:37 PM
News IconTrading Performance and Target Watch for IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Press Telegraph (NASDAQ:IDXX) - July 15 at 9:01 AM
News IconStock Wooing Investors After Increase: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Telanagana Press (NASDAQ:IDXX) - July 14 at 9:06 AM logoRuane Cunniff Comments on Idexx Laboratories (NASDAQ:IDXX) - July 13 at 6:27 PM logoSequoia Fund Addresses Valeant, New Buys, Board Changes in 2nd Quarter Letter (NASDAQ:IDXX) - July 13 at 5:58 PM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:IDXX) - July 13 at 8:28 AM
News IconShares Moving Up Over the Past Quarter: IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Engelwood Daily (NASDAQ:IDXX) - July 12 at 9:56 AM


Idexx Laboratories (NASDAQ:IDXX) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff